Literature DB >> 19526278

Molecular and neurochemical mechanisms in PD pathogenesis.

Irmgard Paris1, Jorge Lozano, Carolina Perez-Pastene, Patricia Muñoz, Juan Segura-Aguilar.   

Abstract

Oxidation of dopamine to aminochrome seems to be a normal process leading to aminochrome polymerization to form neuromelanin, since normal individuals have this pigment in their dopaminergic neurons in the substantia nigra. The neurons lost in individuals with Parkinson's disease are dopaminergic neurons containing neuromelanin. This raises two questions. First, why are those cells containing neuromelanin lost in this disease? Second, what is the identity of the neurotoxin that induces this cell death? We propose that aminochrome is the agent responsible for the death of dopaminergic neurons containing neuromelanin in individuals with Parkinson's disease. The normal oxidative pathway of dopamine, in which aminochrome polymerizes to form neuromelanin, can be neurotoxic if DT-diaphorase is inhibited under certain conditions. Inhibition of DT-diaphorase allows two neurotoxic reactions to proceed: (i) the formation of aminochrome adducts with alpha-synuclein, which induce and stabilize the formation of neurotoxic protofibrils; and (ii) the one electron reduction of aminochrome to the neurotoxic leukoaminochrome o-semiquinone radical. Therefore, we propose that DT-diaphorase is an important neuroprotective enzyme in dopaminergic neurons containing neuromelanin.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19526278     DOI: 10.1007/s12640-009-9059-4

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  87 in total

Review 1.  Methionine oxidation, alpha-synuclein and Parkinson's disease.

Authors:  Charles B Glaser; Ghiam Yamin; Vladimir N Uversky; Anthony L Fink
Journal:  Biochim Biophys Acta       Date:  2004-11-25

2.  Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct.

Authors:  K A Conway; J C Rochet; R M Bieganski; P T Lansbury
Journal:  Science       Date:  2001-11-09       Impact factor: 47.728

3.  Alpha-synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells.

Authors:  Xiangmin Peng; Xiangmin M Peng; Roya Tehranian; Paula Dietrich; Leonidas Stefanis; Ruth G Perez
Journal:  J Cell Sci       Date:  2005-07-19       Impact factor: 5.285

4.  Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of alpha-synuclein.

Authors:  Katerina E Paleologou; Adrian W Schmid; Carla C Rospigliosi; Hai-Young Kim; Gonzalo R Lamberto; Ross A Fredenburg; Peter T Lansbury; Claudio O Fernandez; David Eliezer; Markus Zweckstetter; Hilal A Lashuel
Journal:  J Biol Chem       Date:  2008-03-14       Impact factor: 5.157

5.  Copper neurotoxicity in rat substantia nigra and striatum is dependent on DT-diaphorase inhibition.

Authors:  Gabriela Díaz-Véliz; Irmgard Paris; Sergio Mora; Rita Raisman-Vozari; Juan Segura-Aguilar
Journal:  Chem Res Toxicol       Date:  2008-05-23       Impact factor: 3.739

6.  The possible role of one-electron reduction of aminochrome in the neurodegenerative process of the dopaminergic system.

Authors:  J Segura-Aguilar; D Metodiewa; S Baez
Journal:  Neurotox Res       Date:  2001-04       Impact factor: 3.911

7.  MPP(+)-induced degeneration is potentiated by dicoumarol in cultures of the RCSN-3 dopaminergic cell line. Implications of neuromelanin in oxidative metabolism of dopamine neurotoxicity.

Authors:  R Aguilar Hernández; M J Sánchez De Las Matas; C Arriagada; C Barcia; P Caviedes; M T Herrero; J Segura-Aguilar
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

8.  Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils.

Authors:  Hilal A Lashuel; Benjamin M Petre; Joseph Wall; Martha Simon; Richard J Nowak; Thomas Walz; Peter T Lansbury
Journal:  J Mol Biol       Date:  2002-10-04       Impact factor: 5.469

Review 9.  The 6-hydroxydopamine model of Parkinson's disease.

Authors:  Nicola Simola; Micaela Morelli; Anna R Carta
Journal:  Neurotox Res       Date:  2007-04       Impact factor: 3.911

10.  Inhibition of VMAT-2 and DT-diaphorase induce cell death in a substantia nigra-derived cell line--an experimental cell model for dopamine toxicity studies.

Authors:  Patricio Fuentes; Irmgard Paris; Melissa Nassif; Pablo Caviedes; Juan Segura-Aguilar
Journal:  Chem Res Toxicol       Date:  2007-04-11       Impact factor: 3.739

View more
  13 in total

1.  Aminochrome induces disruption of actin, alpha-, and beta-tubulin cytoskeleton networks in substantia-nigra-derived cell line.

Authors:  Irmgard Paris; Carolina Perez-Pastene; Sergio Cardenas; Patricio Iturriaga-Vasquez; Patricio Iturra; Patricia Muñoz; Eduardo Couve; Pablo Caviedes; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2010-01-20       Impact factor: 3.911

2.  DT-Diaphorase Prevents Aminochrome-Induced Alpha-Synuclein Oligomer Formation and Neurotoxicity.

Authors:  Patricia Muñoz; Sergio Cardenas; Sandro Huenchuguala; Andrea Briceño; Eduardo Couve; Irmgard Paris; Juan Segura-Aguilar
Journal:  Toxicol Sci       Date:  2015-01-28       Impact factor: 4.849

3.  3,4-Dihydroxyphenylacetaldehyde Is More Efficient than Dopamine in Oligomerizing and Quinonizing α-Synuclein.

Authors:  Yunden Jinsmaa; Risa Isonaka; Yehonatan Sharabi; David S Goldstein
Journal:  J Pharmacol Exp Ther       Date:  2019-11-19       Impact factor: 4.030

Review 4.  The catecholaldehyde hypothesis: where MAO fits in.

Authors:  David S Goldstein
Journal:  J Neural Transm (Vienna)       Date:  2019-12-05       Impact factor: 3.575

5.  Autophagy protects against aminochrome-induced cell death in substantia nigra-derived cell line.

Authors:  Irmgard Paris; Patricia Muñoz; Sandro Huenchuguala; Eduardo Couve; Laurie H Sanders; John Timothy Greenamyre; Pablo Caviedes; Juan Segura-Aguilar
Journal:  Toxicol Sci       Date:  2011-04-06       Impact factor: 4.849

6.  One-electron reduction of 6-hydroxydopamine quinone is essential in 6-hydroxydopamine neurotoxicity.

Authors:  Monica Villa; Patricia Muñoz; Ulises Ahumada-Castro; Irmgard Paris; Ana Jiménez; Isabel Martínez; Francisca Sevilla; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2013-02-06       Impact factor: 3.911

Review 7.  Animal models of Parkinson's disease: limits and relevance to neuroprotection studies.

Authors:  Erwan Bezard; Zhenyu Yue; Deniz Kirik; Maria Grazia Spillantini
Journal:  Mov Disord       Date:  2012-07-02       Impact factor: 10.338

8.  Lipid-mediated oxidative stress and inflammation in the pathogenesis of Parkinson's disease.

Authors:  Tahira Farooqui; Akhlaq A Farooqui
Journal:  Parkinsons Dis       Date:  2011-02-15

9.  Combined enrichment of neuromelanin granules and synaptosomes from human substantia nigra pars compacta tissue for proteomic analysis.

Authors:  S Plum; S Helling; C Theiss; R E P Leite; C May; W Jacob-Filho; M Eisenacher; K Kuhlmann; H E Meyer; P Riederer; L T Grinberg; M Gerlach; K Marcus
Journal:  J Proteomics       Date:  2013-08-03       Impact factor: 4.044

Review 10.  The Catecholaldehyde Hypothesis for the Pathogenesis of Catecholaminergic Neurodegeneration: What We Know and What We Do Not Know.

Authors:  David S Goldstein
Journal:  Int J Mol Sci       Date:  2021-06-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.